DENTON, Texas , March 25, 2025 /PRNewswire/ -- HealthTrackRx, the nation's premier provider of molecular diagnostic testing, announces the appointment of Dana Simonds , CHC, CHPC, as its new Chief Compliance Officer. A recognized leader in diagnostic laboratory compliance, Simonds brings deep expertise in regulatory strategy, risk management, and operational integrity, further solidifying HealthTrackRx's position as a trusted industry leader. Simonds has spent more than two decades shaping compliance programs at some of the most respected healthcare organizations, including Sonic Healthcare USA , Inform Diagnostics, and UnitedHealthcare.
Her leadership has driven best-in-class compliance frameworks, enhanced risk mitigation strategies, and fostered collaborative cultures of integrity across laboratory and healthcare settings. "Dana's leadership in compliance and risk management brings further depth to our management team," said Martin Price , CEO of HealthTrackRx. "As we continue our rapid growth, her deep expertise in diagnostics will be instrumental in maintaining our reputation for integrity, patient safety, and operational excellence.
" As Chief Compliance Officer, Simonds will oversee compliance strategy, regulatory adherence, and risk management, ensuring HealthTrackRx remains a leader in molecular diagnostics while upholding the highest standards of ethics, security, and patient care. "HealthTrackRx has built a reputation for innovation, speed, and quality, all of which.
